Drug Profile
Monoclonal antibody PMA5
Latest Information Update: 30 Apr 2002
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Class Antiplatelets; Monoclonal antibodies
- Mechanism of Action Fibrinogen inhibitors; GPIIb-IIIa antagonists; Platelet aggregation inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Thrombosis
Most Recent Events
- 11 Feb 1997 Preclinical development for Thrombosis in Japan (Unknown route)
- 10 Feb 1997 New profile